KKR invests $475 million for 49% stake in Alexandria’s San Diego life‑science Campus Point megacampus
KKR has entered a joint‑venture with Alexandria Real Estate Equities, providing $475 million for a 49% non‑controlling equity interest in the Campus Point megacampus in San Diego. The investment gives KKR about 28.5% indirect ownership of the underlying property while Alexandria retains operational control. The nearly 2 million‑square‑foot campus is 98% leased to major life‑science tenants such as Novartis, Bristol Myers Squibb and Eli Lilly.
Why it matters
The capital infusion gives Alexandria liquidity to fund further development and tenant improvements, supporting its growth strategy. For KKR, the deal adds exposure to a high‑quality, long‑term income‑generating life‑science real‑estate asset.
Key facts
- 1$475 million joint‑venture investment by KKR investing.com
- 2KKR acquired a 49% non‑controlling equity interest in the Campus Point investment entity investing.com
- 3The stake represents approximately 28.5% indirect ownership of the underlying joint venture investing.com
- 4Campus Point comprises nearly 2 million square feet of life‑science space investing.com
- 5Approximately 98% of the campus’s rental revenue is supported by long‑term leases investing.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.